Complement C2 (Middle Region) Peptid
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle Complement C2 Produkte
- Complement C2
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- SRDMTEVISS LENANYKDHE NGTGTNTYAA LNSVYLMMNN QMRLLGMETM
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-C2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Complement C2
- Hintergrund
-
Component C2 is a serum glycoprotein that functions as part of the classical pathway of the complement system. Activated C1 cleaves C2 into C2a and C2b. The serine proteinase C2a then combines with complement factor 4b to create the C3 or C5 convertase. Deficiency of C2 has been reported to associated with certain autoimmune diseases and SNPs in this gene have been associated with altered susceptibility to age-related macular degeneration. This gene localizes within the class III region of the MHC on the short arm of chromosome 6. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional transcript variants have been described in publications but their full-length sequence has not been determined.
Alias Symbols: CO2, ARMD14
Protein Size: 506 - Gen-ID
- 717
- NCBI Accession
- NM_001282457, NP_001269386
- UniProt
- B4DQI1
-
Sie sind hier:
